HIV and hepatitis C virus infections among hanka injection drug users in central Ukraine: A cross-sectional survey

Harm Reduction Journal

Volumn 6, Issue , 2009, Pages 23-

  Dumchev, Kostyantyn V ^a   Soldyshev, Ruslan ^b   Qian, Han Zhu ^c   Zezyulin, Olexandr O ^a   Chandler, Susan D ^d   Slobodyanyuk, Pavel ^a   Moroz, Larisa ^e   Schumacher, Joseph E ^d  

^a Vinnitsya Regional Narcological Dispensary ^*  (Ukraine)

^b UNIVERSITY OF MISSOURI   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d University of Alabama at Birmingham   (United States)

^e NATIONAL PIROGOV MEMORIAL MEDICAL UNIVERSITY   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPINE DERIVATIVE; DIPHENHYDRAMINE; HANKA; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HYPNOTIC AGENT; OPIATE; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; FEMALE; HARM REDUCTION; HEALTH PROGRAM; HEALTH SURVEY; HEPATITIS C; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROSTITUTION; RISK FACTOR; SEXUAL BEHAVIOR; STRUCTURED INTERVIEW; UKRAINE;

EID: 71049186333     PISSN: None     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/1477-7517-6-23     Document Type: Article

References (34)

1. Barcal K, Schumacher JE, Dumchev K, Moroz LV: A situational picture of HIV/AIDS and injection drug use in Vinnitsya, Ukraine. Harm Reduction Journal 2005, 2:16 [http://www.harmre ductionjournal.com/content/pdf/1477-7517-2-16.pdf]. Retrieved August 18, 2008
2. Ministry of Health of Ukraine: HIV infection in Ukraine. Informational bulletin #30. Kyiv 2008. (in Ukrainian).
3. Poznyak VB, Pelipas VE, Vievski AN, Miroshnichenko L: Illicit drug use and its health consequences in Belarus, Russian Federation and Ukraine: Impact of transition. European Addiction Research 2002, 8:184-189.
4. Ministry of Health of Ukraine, Center of Medical Statistics: Statistical report for 2008. Kyiv 2009. (in Ukrianian).
5. Kruglov YV, Kobyshcha YV, Salyuk T, Varetska O, Shakarishvili A, Saldanha VP: The most severe HIV epidemic in Europe: Ukraine's national HIV prevalence estimates for 2007. Sexually Transmitted Infections 2008, 84(Suppl I):i37-i41. doi:10.1136/ sti.2008.031195
6. Vinnitsya Regional Epidemiology and Sanitation Station: End-year report 2003. Vinnitsya 2003.
7. Ukrainian Institute for Social Research: WHO Drug Injecting Study Phase II: Survey report 2002. Kyiv 2002.
8. Booth RE, Kwiatkowski CF, Mikulich-Gilbertson SK, Brewster JT, Salomonsen-Sautel S, Coursi KF, Sinitsyna L: Predictors of risky needle use following interventions with injection drug users. Drug and Alcohol Dependence 2006, 82(Suppl 1):S49-S55.
9. Kruglov J: Introduction. In Viral Hepatitis in Injection Drug Users: Prevention, Natural History, Treatment, HIV Coinfection Edited by: Kruglov J.Kyiv: AIDS Foundation East-West; 2004:5-6.
10. Khoronzhevskaia-Muliar I: Spread of infection with hepatitis B and C viruses in different population groups of north-western Ukraine. Zhurnal mikrobiologii, epidemiologii, i immunobiologii 2000, 5:35-39.
11. Booth RE, Kwiatkowski CF, Brewster JT, Sinitsyna L, Dvoryak S: Predictors of HIV sero-status among drug injectors at three Ukraine sites. AIDS 2006, 20:2217-2223.
12. Vinnitsya Regional AIDS Center: End-year report 2008. Vinnitsya, Ukraine 2008.
13. Vinnitsya Regional Narcological Dispensary: End-year report 2008. Vinnitsya, Ukraine 2008.
14. International HIV/AIDS Alliance: What official statistics say: AIDS in Ukraine. Analytical Review 2003, 1(3):. (in Ukrainian)
15. Kaplan CD, Korf D, Sterk C: Temporal and social contexts of heroin-using populations. An illustration of the snowball sampling technique. The Journal of Nervous and Mental Disease 1987, 175:566-574.
16. Centers for Disease Control and Prevention: Revised guidelines for HIV counseling, testing, and referral and revised recommendations for HIV screening of pregnant women. Morbidity and Mortality Weekly Report 2001, 50(RR-19)
17. Carey MP, Morrison-Beedy D, Johnson BT: The HIV-Knowledge Questionnaire: Development and evaluation of a reliable, valid, and practical self-administered questionnaire. AIDS and Behavior 1997, 1(1):61-74.
18. Miller WR: Manual for Form 90: A structured assessment interview for drinking and related behaviors. In Project MATCH Monograph Series Volume 5. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism; 1996.
19. Metzger D, Woody GE, Navaline H, McLellan AT, Meyers K, Boney T: The Risk Assessment Battery (RAB): Validity and reliability. Paper presented at the Sixth Annual Meeting of National Cooperative Vaccine Development Group for AIDS; 1993.
20. UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance: Epidemiological Fact Sheets on HIV/AIDS and Sexually Transmitted Infections, 2006 Update. Geneva 2006.
21. Ciccarone D, Bourgois P: Explaining the geographical variation of HIV among injection drug users in the United States. Substance Use and Misuse 2003, 38(14):2049-2063.
22. Shapatava E, Nelson KE, Tsertsvadze T, del Rio C: Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia. Drug and Alcohol Dependence 2006, 82:S35-S38.
23. Jittiwutikarn J, Thongsawat S, Suriyanon V, Maneekarn N, Celentano D, Razak MH, Srirak N, Vongchak T, Kawichai S, Thomas D, Sripaipan T, Netski D, Ananthakrishnan A, Nelson KE: Hepatitis C infection among drug users in northern Thailand. The American Journal of Tropical Medicine and Hygiene 2006, 74:1111-1116.
24. Ruan YH, Hong KX, Liu SZ, He YX, Zhou F, Qin GM, Chen KL, Xing H, Chen JP, Shao YM: Community-based survey of HCV and HIV coinfection in injection drug abusers in Sichuan Province of China. World Journal of Gastroenterology 2004, 10:1589-1593.
25. Rhodes T, Platt L, Maximova S, Koshkina E, Latishevskaya N, Hickman M, Renton A, Bobrova N, McDonald T, Parry JV: Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study. Addiction 2006, 101:252-266.
26. Alter M: Epidemiology of viral hepatitis and HIV co-infection. Journal of Hepatology 2006, 44:S6-S9.
27. Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson J, Monterroso ER, Garfein RS: Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. American Journal of Epidemiology 2002, 155(7):645-653.
28. Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M: Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bulletin of the World Health Organization 1999, 77(10):789-800.
29. Fried M, Shiffman M, Reddy R, Smith C: Ministry of Health of Ukraine End-year Report 2005. Kyiv 2005. (in Ukrainian)
30. Bing EG, Hays RD, Jacobson LP, Chen B, Gange SJ, Kass NE, Chmiel JS, Zucconi SL: Health-related quality of life among people with HIV disease: results from the Multicenter AIDS Cohort Study. Quality of Life Research 2000, 9:5-63.
31. Marinos G, Goncales FL, Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J: Peginterferon alfa- 2a plus ribavirin for chronic hepatitis C virus infection. New England Journal of Medicine 2002, 347:975-982.
32. Soriano V, Puoti M, Sulkowski M, Mauss S, Cacoub P, Cargnel A, Dieterich D, Hatzakis A, Rockstroh J: Care of patients with hepatitis C and HIV co-infection. AIDS 2004, 18:1-12.
33. Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD: Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections. Hepatology 2002, 35:182-189.
34. George SL, Gebhardt J, Klinzman D, Foster MB, Patrick KD, Schmidt WN, Alden B, Pfaller MA, Stapleton JT: Hepatitis C virus viremia in HIV-infected individualswith negative HCV antibody tests. Journal of Acquired Immune Deficiency Syndrome 2002, 31:154-162.